Marex Group plc Ordinary Shares
NASDAQ:MRXFinancial - Capital Markets
+$0.93 today
- Market cap
- $4.61B
- Beta
- -0.00
- P/E (TTM)
- 14.5
- EPS (TTM)
- $4.32
- Dividend yield
- 0.98%
Volume 0.83M
Average 1.11M
Fair Value & DCF
Compare our fair value with your own assumptions
Intrinsic Alpha selects a valuation method suited to the business. Use the calculator below to build an independent scenario with your preferred cash-flow basis.
Marex Group plc Ordinary Shares
NASDAQ:MRX
Intrinsic Alpha fair value
Locked
Current Price
$64.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Build your own valuation
Test an independent scenario and compare it with Intrinsic Alpha's estimate.
Sign in to use the DCF calculator
Free accounts get 5 valuations per week. Upgrade for more.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +41.7% | +28.2% (4yr)3 analysts |
| Revenue | N/A | N/A | +45.6% | +46.6% (4yr)2 analysts |
| Net Income | N/A | N/A | +49.8% | +26.8% (4yr)2 analysts |
| EBIT | N/A | N/A | +62.5% | -1.9% (4yr)2 analysts |
Analysis
Recent growth has been strongest in EBIT at +62.5% over three years. Forward estimates point to Revenue at +46.6% (4yr), giving you a quick check on whether expectations are accelerating or cooling.
Estimates & History
Historical data and analyst estimates. Solid bars are actuals; dashed-border bars are future estimates.
Competitor Valuations
Peer stocks ranked by intrinsic value status
| Company | Market Cap | Price | Valuation | P/E | 1Y Return |
|---|---|---|---|---|---|
Morgan Stanley NYSE:MS | $300.71B | $190.65 | Overvalued | 19.5 | +12.85% |
The Goldman Sachs Group, Inc. NYSE:GS | $264.37B | $916.56 | Overvalued | 18.5 | +12.73% |
Nasdaq, Inc. NASDAQ:NDAQ | $60.20B | $108.47 | Overvalued | 24.4 | +24.10% |
Tradeweb Markets Inc. NASDAQ:TW | $28.68B | $132.74 | Overvalued | 24.4 | +19.15% |
Stifel Financial Corp. NYSE:SF | $10.86B | $72.75 | Undervalued | 8.6 | -9.58% |
Jefferies Financial Group Inc. NYSE:JEF | $8.64B | $45.69 | Overvalued | 18.0 | -21.41% |
StoneX Group Inc. NASDAQ:SNEX | $6.90B | $57.24 | Undervalued | 21.9 | -7.14% |
MarketAxess Holdings Inc. NASDAQ:MKTX | $5.82B | $165.22 | Overvalued | 13.9 | -0.08% |
BGC Group, Inc NASDAQ:BGC | $5.17B | $11.10 | Overvalued | 32.2 | +32.98% |
Continue the stock analysis
Jump to another research area for this company.